Jayakar V. Nayak

Dr. Jayakar V. Nayak


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2023 in International Forum of Allergy & Rhinology
Verified
Journal Article
Open access
SWSarah K. Wise
Sarah K. Wise
CDCecelia Damask
Cecelia Damask
LRLauren T. Roland
Lauren T. Roland
CECharles Ebert
Charles Ebert
JLJoshua Levy
Joshua Levy
LZLuo Zhang
Luo Zhang
Background: In the 5 years that have passed since the publication of the 2018 International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (ICAR‐Allergic Rhinitis 2018), the literature has expanded substantially. The ICAR‐Allergic Rhinitis 2023 update presents 144 individual topics on allergic rhinitis (AR), expanded by over 40 topics from the 2018 document. Originally presented topics from 2018 have also been reviewed and updated. The executive summary highlights key evidence‐based findings and recommendation from the full document.Methods: ICAR‐Allergic Rhinitis 2023 employed established evidence‐based review with recommendation (EBRR) methodology to individually evaluate each topic. Stepwise iterative peer review and consensus was performed for each topic. The final document was then collated and includes the results of this work.Results: ICAR‐Allergic Rhinitis 2023 includes 10 major content areas and 144 individual topics related to AR. For a substantial proportion of topics included, an aggregate grade of evidence is presented, which is determined by collating the levels of evidence for each available study identified in the literature. For topics in which a diagnostic or therapeutic intervention is considered, a recommendation summary is presented, which considers the aggregate grade of evidence, benefit, harm, and cost.Conclusion: The ICAR‐Allergic Rhinitis 2023 update provides a comprehensive evaluation of AR and the currently available evidence. It is this evidence that contributes to our current knowledge base and recommendations for patient evaluation and treatment.

28 October 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
ILIvan T. Lee
Ivan T. Lee
TNTsuguhisa Nakayama
Tsuguhisa Nakayama
CWChien-Ting Wu
Chien-Ting Wu
YGYury Goltsev
Yury Goltsev
SJSizun Jiang
Sizun Jiang
PJPeter K. Jackson
Peter K. Jackson
The coronavirus SARS-CoV-2 is the causative agent of the ongoing severe acute respiratory disease pandemic COVID-19. Tissue and cellular tropism is one key to understanding the pathogenesis of SARS-CoV-2. We investigate the expression and subcellular localization of the SARS-CoV-2 receptor, angiotensin-converting enzyme 2 (ACE2), within the upper (nasal) and lower (pulmonary) respiratory tracts of human donors using a diverse panel of banked tissues. Here, we report our discovery that the ACE2 receptor protein robustly localizes within the motile cilia of airway epithelial cells, which likely represents the initial or early subcellular site of SARS-CoV-2 viral entry during host respiratory transmission. We further determine whether ciliary ACE2 expression in the upper airway is influenced by patient demographics, clinical characteristics, comorbidities, or medication use, and show the first mechanistic evidence that the use of angiotensin-converting enzyme inhibitors (ACEI) or angiotensin II receptor blockers (ARBs) does not increase susceptibility to SARS-CoV-2 infection through enhancing the expression of ciliary ACE2 receptor. These findings are crucial to our understanding of the transmission of SARS-CoV-2 for prevention and control of this virulent pathogen.

1 February 2020 in Cell Stem Cell
Verified
Journal Article
Closed access
SVSriram Vaidyanathan
Sriram Vaidyanathan
ASAmeen A. Salahudeen
Ameen A. Salahudeen
ZSZachary M. Sellers
Zachary M. Sellers
DBDawn T. Bravo
Dawn T. Bravo
SCShannon S. Choi
Shannon S. Choi
MPMatthew H. Porteus
Matthew H. Porteus

24 August 2016 in International Forum of Allergy & Rhinology
Verified
Journal Article
Closed access
PDF file
NVNathalia Velasquez
Nathalia Velasquez
ATAndrew Thamboo
Andrew Thamboo
AHAl‐Rahim R. Habib
Al‐Rahim R. Habib
ZHZhenxiao Huang
Zhenxiao Huang
JNJayakar V. Nayak
Jayakar V. Nayak

1 April 2022 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
TNTsuguhisa Nakayama
Tsuguhisa Nakayama
ILIvan T. Lee
Ivan T. Lee
WLWei Le
Wei Le
YTYasuhiro Tsunemi
Yasuhiro Tsunemi
NBNicole A. Borchard
Nicole A. Borchard
JNJayakar V. Nayak
Jayakar V. Nayak

27 March 2017 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
ATAndrew Thamboo
Andrew Thamboo
NVNathalia Velasquez
Nathalia Velasquez
AHAl‐Rahim R. Habib
Al‐Rahim R. Habib
DZDavid Zarabanda
David Zarabanda
HPHassan Paknezhad
Hassan Paknezhad
JNJayakar V. Nayak
Jayakar V. Nayak